Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

This study is currently recruiting participants.

Verified by Stanford University, September 2008

Sponsors and Collaborators:	Stanford University National Institutes of Health (NIH) The Leukemia and Lymphoma Society Biospect Inc
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00398177

Purpose

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Condition
Lymphoma, Non-Hodgkin

MedlinePlus related topics: Hodgkin's Disease Lymphoma

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Further study details as provided by Stanford University:

Estimated Enrollment:	9999
Study Start Date:	June 1999

Detailed Description:

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:- Any type of NHL or Hodgkin,s disease.
 Exclusion Criteria:- Patients without NHL or Hodgkin's disease

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00398177

Locations

United States, California
Stanford University School of Medicine	Recruiting
Stanford, California, United States, 94305
Contact: Cancer Clinical Trials Office 650-498-7061 cctoffice@stanford.edu
Contact: Cancer Clinical Trials Office (650) 498-7061 cctoffice@stanford.edu
Principal Investigator: Ronald Levy
Sub-Investigator: Ramsey Cheung
Sub-Investigator: Gideon Gross

Sponsors and Collaborators

Stanford University

National Institutes of Health (NIH)

The Leukemia and Lymphoma Society

Biospect Inc

Investigators

Principal Investigator:

Ronald Levy

Stanford University

More Information

Study ID Numbers:	LYM0001, 76973, LYM0001, NCT00398177
Study First Received:	November 9, 2006
Last Updated:	October 3, 2008
ClinicalTrials.gov Identifier:	NCT00398177
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lymphatic Diseases
Hodgkin's disease
Immunoproliferative Disorders
Hodgkin lymphoma, adult
Lymphoma, small cleaved-cell, diffuse

Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Hodgkin Disease
Lymphoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Histologic Type
Immune System Diseases

ClinicalTrials.gov processed this record on January 16, 2009